Most recent articles by:

Ben Stevens

- Advertisement -spot_img

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from the fallout of a...

MGC Pharmaceuticals Tells Shareholders Pending Deal Could ‘Transform Finances Overnight’

MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away the best financial performance...

Yooma Aiming For Annual Revenues Of $20m-Plus With Buying Spree Set To Continue

YOOMA Wellness saw revenues decline in its third quarter but managed to taper losses as it continued to buy up international CBD and wellness...

Former Prime Minister’s Cannabis Company Delivers 170% Sales Boost

INTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter.  The Israel-based medical cannabis company reported...

Guernsey Issues Its First Medical Cannabis Cultivation Licence To 4C Labs With More Set To Follow

4C LABS has become the first and only company to be awarded a medical cannabis cultivation licence in Guernsey marking a major milestone for...

26-Year-Old Dubliner Becomes Ireland’s First ‘Medical Cannabis Access Programme’ Patient

IRELAND now has its first patient through the state-approved Medical Cannabis Access Programme (MCAP) some four years after it was launched -  but experts...

Danish Cultivator Completes New Facility Gearing Itself For ‘High-Volume Production’

STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards profitability, despite reporting no...

Europe Just Months Away From ‘Recreational Cannabis Domino Effect’, Says Curaleaf Chief

CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in preparation for what it...

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...
- Advertisement -spot_img